Document is current
Any future updates will be listed below
-
Authors
Durán, Verónica
Nikolouli, Eirini
Chatterjee, Shambhabi
Costa, Bibiana
Pavlou, Andreas
Ziegler, Annett
Becker, Jennifer
Baumann, Kira
Bruhn, Matthias
Haake, Kathrin
Hashtchin, Anna Rafiei
Gensch, Ingrid
Korte, Andrea
Behrens, Yvonne Lisa
Zhang, Shen-Ying
Casanova, Jean-Laurent
Bär, Christian
Lachmann, Nico
Thum, Thomas
Kalinke, Ulrich https://orcid.org/0000-0003-0503-9564
-
Funding
Funding for this research was provided by:
Helmholtz-Zentrum für Infektionsforschung GmbH (HZI)
- License Information
-
More Information
Article History
Received: 7 December 2023
Accepted: 9 September 2025
First Online: 21 October 2025
Declarations
:
: T.T. filed and licensed patents in the field of noncoding RNAs (outside of the MS). T.T. is founder and CSO/CMO of Cardior Pharmaceuticals GmbH, a wholly owned subsidiary of Novo Nordisk A/S Europe (outside of this MS). N.L. filed and licensed patents in the field of iPSC-derived macrophages to Novo Nordisk A/S (outside of the MS). N.L. receives research funding from Novo Nordisk A/S and is consultant for Evotec International in the field iPSC-derived macrophages. All remaining authors have no conflicts of interest to declare.
